9/23/2026
NeuroThera expands U.S. patent portfolio with Clearmind
New patent applications cover LSD, ketamine, and ibogaine combinations for mental health.
Topic archive
2 stories
9/23/2026
New patent applications cover LSD, ketamine, and ibogaine combinations for mental health.
9/10/2026
IBEX011 stability program aims to meet growing demand for standardized ibogaine.